American Trial Using Tranexamic Acid in Thrombocytopenia

Completed · Phase 3 · Has a placebo group

Conditions studied: Thrombocytopenia

In brief

The purpose of this study is to evaluate the usefulness of antifibrinolytic therapy with tranexamic acid (TXA) in preventing bleeding in patients who are thrombocytopenic due to primary bone marrow disorders or chemotherapy, immunotherapy and/or radiation therapy.

Key facts

Study ID

NCT02578901

Run by

University of Washington

People needed

330

Starts

2016-06-01

Expected to finish

2020-06-11

Last updated by the study team

2021-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of North Carolina — Chapel Hill, North Carolina, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.